$DLOC
Digital Locations, Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224018596 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $4.972K
YoY Change -15.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $568.5K $836.6K $937.9K
YoY Change -47.12% -10.8% 0.19%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.00 $500.00 $500.00
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $569.0K $837.1K $938.4K
YoY Change -47.1% -10.79% 0.19%
Operating Profit -$569.0K -$837.1K -$933.4K
YoY Change -46.7% -10.32% 0.28%
Interest Expense $3.033M $1.449M $75.88K
YoY Change 5608.79% 1809.7% -49.68%
% of Operating Profit
Other Income/Expense, Net $3.033M -$5.918M $1.127M
YoY Change -1613.15% -625.13% -13.49%
Pretax Income $2.464M -$6.755M $193.7K
YoY Change -294.31% -3588.47% -47.94%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $2.464M -$6.755M $193.7K
YoY Change -294.31% -3588.47% -47.94%
Net Earnings / Revenue 3894.85%
Basic Earnings Per Share $0.00 -$0.01 $0.00
Diluted Earnings Per Share $0.00 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 733.8M shares 733.8M shares 665.7M shares
Diluted Shares Outstanding 8.360B shares 733.8M shares 4.550B shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.69K $49.36K $22.90K
YoY Change 267.35% 115.55% -68.15%
Cash & Equivalents $37.69K $49.36K $22.90K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $37.69K $49.36K $22.90K
YoY Change 267.44% 115.54% -68.15%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $3.000K $3.500K $5.500K
YoY Change -40.0% -36.36%
Long-Term Investments
YoY Change
Other Assets $500.00 $500.00 $500.00
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $3.500K $4.000K $6.000K
YoY Change -36.36% -33.33% -25.0%
TOTAL ASSETS
Total Short-Term Assets $37.69K $49.36K $22.90K
Total Long-Term Assets $3.500K $4.000K $6.000K
Total Assets $41.19K $53.36K $28.90K
YoY Change 161.4% 84.63% -63.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $122.2K $133.0K $122.1K
YoY Change -0.03% 8.96% -23.83%
Accrued Expenses $146.2K $101.5K $56.84K
YoY Change 151.09% 78.5% -13.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $883.7K $528.9K $88.10K
YoY Change 903.11% 500.35% -51.81%
Total Short-Term Liabilities $6.125M $9.009M $277.0K
YoY Change 1011.92% 3152.56% -94.9%
LONG-TERM LIABILITIES
Long-Term Debt $698.8K $649.0K $448.5K
YoY Change 40.22% 44.69% 80.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $698.8K $649.0K $448.5K
YoY Change 40.22% 44.69% 80.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.125M $9.009M $277.0K
Total Long-Term Liabilities $698.8K $649.0K $448.5K
Total Liabilities $6.824M $9.658M $725.5K
YoY Change 550.38% 1231.24% -87.22%
SHAREHOLDERS EQUITY
Retained Earnings -$59.18M -$61.64M -$49.97M
YoY Change 15.5% 23.36%
Common Stock $733.8K $733.8K $733.8K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.71M -$15.53M -$6.353M
YoY Change
Total Liabilities & Shareholders Equity $41.19K $53.36K $28.90K
YoY Change 161.4% 84.63% -63.83%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $2.464M -$6.755M $193.7K
YoY Change -294.31% -3588.47% -47.94%
Depreciation, Depletion And Amortization $500.00 $500.00 $500.00
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$221.7K -$469.7K -$180.2K
YoY Change -34.35% 160.66% 5.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 210.0K $475.0K $172.0K
YoY Change -35.38% 176.16% -1.71%
NET CHANGE
Cash From Operating Activities -221.7K -$469.7K -$180.2K
Cash From Investing Activities $0.00
Cash From Financing Activities 210.0K $475.0K $172.0K
Net Change In Cash -11.67K $5.256K -$8.212K
YoY Change -7.75% -164.0% -331.72%
FREE CASH FLOW
Cash From Operating Activities -$221.7K -$469.7K -$180.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2024Q1 DLOC Settlement Of Derivative Liabilities
SettlementOfDerivativeLiabilities
usd
CY2023Q1 DLOC Debt Discount For Derivative Liabilities
DebtDiscountForDerivativeLiabilities
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
836596 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
937860 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
837096 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
938360 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-837096 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-933388 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1449100 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
75881 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4469303 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1202921 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5918403 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1127040 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6755499 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
193652 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6755499 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
193652 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
733766705 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
631933083 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
733766705 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4550396166 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9132159 usd
CY2024Q1 DLOC Stock Issued During Period Value Vesting Of Consultant Stock Options
StockIssuedDuringPeriodValueVestingOfConsultantStockOptions
358549 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6755499 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-15529109 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7363543 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
40971 usd
CY2023Q1 DLOC Stock Issued During Period Value Vesting Of Consultant Stock Options
StockIssuedDuringPeriodValueVestingOfConsultantStockOptions
745448 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
30758 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
193652 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6352714 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6352714 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6755499 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
193652 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
291252 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
72122 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1134404 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4469303 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1202921 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
358549 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
745448 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8651 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8868 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
293 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-506 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
22803 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2625 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-469744 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180212 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
475000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
172000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
475000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5256 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8212 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44104 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31113 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49360 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22901 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
40971 usd
CY2023Q1 DLOC Settlement Of Derivative Liabilities
SettlementOfDerivativeLiabilities
30758 usd
CY2024Q1 DLOC Debt Discount For Derivative Liabilities
DebtDiscountForDerivativeLiabilities
475000 usd
CY2024Q1 DLOC Working Capital Deficit
WorkingCapitalDeficit
8960049 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61643243 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zTihvY21xR9f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zLo7rNc5ynY">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment and intangible assets, operating lease obligations, impairment of assets, the deferred tax valuation allowance, the fair value of stock options and derivative liabilities. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2166112 usd
CY2024Q1 DLOC Addition To Liabilities For New Debtshares Issued
AdditionToLiabilitiesForNewDebtsharesIssued
1609404 usd
CY2024Q1 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
4469303 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
8244819 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2166112 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2166112 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8244819 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8244819 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zYtGkxiX5LW3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zCeQouSLphF9">Concentrations of Credit Risk, Major Customers, and Major Vendors</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and 2023, the Company received payments from two cell phone carriers, with one carrier representing substantially all payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and 2023, the Company had one landlord receiving all Company payments for lease of billboard site locations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
631933083 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
147729750 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4550396166 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7371837045 shares
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zcNippT2xaLi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_z71UACK1wkgi">Reclassifications</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the condensed consolidated financial statements for the prior year periods have been reclassified to conform to the presentation for the current year periods.</span></p>
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
20000000 shares
CY2024Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
733766705 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
733766705 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
733766705 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
733766705 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
358549 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
745448 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1001436 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
904177778 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.004
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M3D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
904177778 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.004
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1504800 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
722733325 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.005
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M29D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1133122 usd
CY2024Q1 DLOC Sharebased Compensation Arrangement By Sharebased Payment Award Options Intrinsic Value Price Share
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIntrinsicValuePriceShare
0.0028
CY2023 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.0006
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
205000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
1/36th per month
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
0.017
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
1/36th per month
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
0.0081
CY2023 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.0006
CY2022Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P12M
CY2024Q1 us-gaap Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
we further extended the lease arrangement for another twelve-month term
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
500 usd
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
500 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1860 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1860 usd

Files In Submission

Name View Source Status
0001493152-24-018596-index-headers.html Edgar Link pending
0001493152-24-018596-index.html Edgar Link pending
0001493152-24-018596.txt Edgar Link pending
0001493152-24-018596-xbrl.zip Edgar Link pending
dloc-20240331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
dloc-20240331_def.xml Edgar Link unprocessable
dloc-20240331_lab.xml Edgar Link unprocessable
dloc-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dloc-20240331_cal.xml Edgar Link unprocessable